IE
SHPH icon

Israel Englander’s Shuttle Pharmaceuticals SHPH Stock Holding History

Israel Englander’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5
Closed -$14K – 6633
2023
Q1 		$14K Sell
5
-5
-50% -$17.9K ﹤0.01% 5951
2022
Q4 		$41K Sell
10
-5
-33% -$24.3K ﹤0.01% 5850
2022
Q3 		$137K Buy
+15
New +$611K ﹤0.01% 5848

Other funds holding SHPH

AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Israel Englander's SHPH Position: Q2 2023 in Review

Israel Englander sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2023, closing a stake of 5 shares — an estimated $14K sold.

Israel Englander first reported a position in SHPH in Q3 2022 and held it in 3 quarters. The position peaked at $137K in Q3 2022. 2 funds tracked by Wall St. Rank hold SHPH as of Q2 2023.

  • Israel Englander reported no remaining Shuttle Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Israel Englander sold 5 Shuttle Pharmaceuticals shares in Q2 2023, an estimated $14K.
  • Israel Englander first reported a position in Shuttle Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Israel Englander's Shuttle Pharmaceuticals position peaked at $137K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.